HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,600 | +3.8% | 13,000 | -2.0% | 0.00% | 0.0% |
| Q2 2023 | $478,505 | -49.3% | 13,266 | -46.3% | 0.00% | -50.0% |
| Q1 2023 | $943,293 | -28.2% | 24,700 | +6.9% | 0.00% | -50.0% |
| Q4 2022 | $1,314,390 | +174.7% | 23,100 | +74.1% | 0.01% | +700.0% |
| Q2 2022 | $478,505 | +71.5% | 13,266 | +25.2% | 0.00% | 0.0% |
| Q3 2020 | $279,000 | -87.0% | 10,600 | -86.8% | 0.00% | -87.5% |
| Q2 2020 | $2,147,000 | +1054.3% | 80,100 | +662.9% | 0.01% | +700.0% |
| Q4 2019 | $186,000 | +5.1% | 10,500 | -8.0% | 0.00% | 0.0% |
| Q3 2019 | $177,000 | -9.7% | 11,412 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $196,000 | +4.8% | 11,439 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $187,000 | +5.6% | 11,616 | -3.7% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -15.3% | 12,061 | +5.0% | 0.00% | 0.0% |
| Q3 2018 | $209,000 | – | 11,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |